Could this patient's gynecologist have prevented the postsurgical necrotizing infection? See what the jury decided.
For details on the lawsuit, click "Next".
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More